Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

10D8194EDF5C4848872586E200119034 Hearing Summary


Date May 26, 2021      
Location SCR 357

HB21-1307 - Committee Discussion Only

09:11:52 PM  
Senator Donovan,
bill sponsor, presented House Bill 21-1307.  The bill creates the
Insulin Affordability Program in the Department of Regulatory Agencies
(DORA). Beginning January 1, 2022, the program allows eligible individuals
to receive a 12-month prescription for insulin for no more than a $50 copay
for a 30-day supply and an emergency 30-day supply of insulin once per
12-month period for no more than a $35 copay.

Committee questions followed.
09:11:53 PM  
Senator Jaquez Lewis proceeded with witness testimony on the bill. Submitted testimony may be found in Attachment F.
09:20:37 PM  
Katelin Lucariello,
representing PhRMA, testified in opposition to the bill. Gail deVore, representing
self, testified in support of the bill. Brian Warren, representing Biotechnology
Innovation Organization, testified in opposition to the bill. Jeanette
Hensley, representing Colorado Senior Lobby, testified in support of the
bill. Christina Fallabel, American Diabetes Association, testified in support
of the bill.
09:40:56 PM  
Senator Rankin distributed
amendment L.007 (Attachment G). Committee discussion on the amendment ensued.
09:52:57 PM  
The chair laid over the bill and amendment.

Colorado legislature email addresses ending in are no longer active. Please replace with for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details